Gastroenterology and Liver

Hepatocellular Carcinoma & Liver Tumor Management

Hepatocellular carcinoma (HCC) and other primary liver tumors present significant challenges due to late diagnosis and complex treatment decisions. This track will cover advancements in imaging, biomarker identification, and early detection strategies that improve prognosis and patient survival. Cutting-edge therapies, including surgical resection, locoregional interventions, systemic therapies, and immunotherapy, will be explored in depth. Participants will gain insight into multidisciplinary approaches that integrate hepatology, oncology, radiology, and surgery to deliver optimal care for liver tumor patients.

Additionally, the session highlights emerging research in precision oncology, molecular profiling, and personalized treatment planning for liver tumors. Case studies and clinical trial findings will illustrate real-world applications and challenges in managing HCC and rare liver malignancies. Discussions will include monitoring treatment response, managing complications, and improving patient quality of life. This track is designed for hepatologists, oncologists, surgeons, and researchers interested in advancing clinical knowledge, sharing research, and improving outcomes for patients with liver tumors.